Emily Chang is a Oakland, California based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Emily Chang is A178363 for Ophthalmology in California. Emily Chang is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Emily Chang speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Gender:
Female
Practice Address:
3772 Howe St, Oakland, California, 94611-5311
Phone:
510-752-1235
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1003311820
NPI Enumeration Date:
25 Mar, 2018
NPI Last Update On:
29 Sep, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Emily Chang are as mentioned below.
License Number
Specialization
State
Status
A178363
Ophthalmology
California
Primary
Student in an Organized Health Care Education/Training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3772 Howe St, Oakland, California
Zip:
94611-5311
Phone Number:
--
Fax Number:
--
Patients can reach Emily Chang at 3772 Howe St, Oakland, California or can call to book an appointment on 510-752-1235. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.